Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.
LGD 2226 is an androgen receptor agonist.1 It induces reporter activation in a reporter assay using CV-1 cells expressing human androgen receptors (EC50 = 0.2 nM). LGD 2226 (10 mg/kg per day) increases prostate and levator ani muscle weight in orchidectomized (ORDX) rats.2 It increases bone mineral density and breaking strength and decreases periosteal mineral apposition and bone formation rates in ORDX rats when administered at doses of 3 or 10 mg/kg per day. LGD 2226 increases mounting behavior and the number of intromissions and ejaculations in ORDX rats.
WARNING This product is not for human or veterinary use.
1. Discovery of 6-
2. An orally active selective androgen receptor modulator is efficacious on bone, muscle, and sex function with reduced impact on prostate. Endocrinology 148(1), 363-373 (2007).